CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $364,000 | +9.0% | 7,034 | -46.6% | 0.00% | 0.0% |
| Q1 2022 | $334,000 | +25.6% | 13,161 | +79.6% | 0.00% | 0.0% |
| Q4 2021 | $266,000 | +88.7% | 7,326 | -30.4% | 0.00% | – |
| Q2 2021 | $141,000 | -60.9% | 10,523 | +49.4% | 0.00% | -100.0% |
| Q1 2021 | $361,000 | -34.1% | 7,042 | -20.4% | 0.00% | -50.0% |
| Q4 2020 | $548,000 | +13.7% | 8,844 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $482,000 | -4.7% | 8,800 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $506,000 | +42.9% | 8,800 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $354,000 | +0.9% | 8,800 | -0.8% | 0.00% | 0.0% |
| Q4 2019 | $351,000 | – | 8,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |